Classification Information
Pharmaceutical peptide preparations for use in treating cancer, infectious diseases, and central nervous system disorders, consisting of peptide-based PD1 blockade inhibitors linked together by a molecular spacer to create a Bi-Specific Drug, used in combination with recombinant vaccines
Pharmaceuticals